Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BTG plc
DescriptionPolyclonal antibody against rattlesnake venom
Molecular Target Not available
Mechanism of ActionImmune modulation; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationPoisoning
Indication DetailsTreat rattlesnake bite
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today